Diametric Capital, LP Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Diametric Capital, LP

  • $162 Million
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
BUY
$83.14 - $145.99 $182,658 - $320,740
2,197 New
2,197 $320,000
Q3 2020

Nov 13, 2020
SELL
$59.04 - $77.95 $197,902 - $261,288
-3,352 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$29.01 - $74.23 $97,241 - $248,818
3,352 New
3,352 $245,000
Q1 2020

May 15, 2020
SELL
$27.51 - $57.29 $166,242 - $346,203
-6,043 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$40.86 - $57.65 $246,916 - $348,378
6,043 New
6,043 $329,000

Others Institutions Holding BHVN

# of Institutions
11
Shares Held
785K
Call Options Held
0
Put Options Held
0
View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

BHVN Quotes by TradingView
  • Ticker BHVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,645,000
  • Market Cap $3.65B
  • Description
  • Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...
More about BHVN
Track This Portfolio

Track Diametric Capital, LP Portfolio

Follow Diametric Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Diametric Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Diametric Capital, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email